 - Prior anticancer treatment, standard or experimental, within 4 weeks prior to the first dose of ridaforolimus except luteinizing hormone releasing hormone LH-RH agonists; the interval is 2 weeks for signal transduction inhibitors with a half-life known to be 24 hours, and is 6 weeks for nitrosourea or mitomycin. 